CHEK2 and breast carcinoma: We identified groups of missense variants conferring increased risks of breast cancer in ATM, BRCA1, BRCA2, and CHEK2, but not in PALB2. The ORs for BRCA1 and CHEK2 decreased with age at diagnosis, consistent with previous observations for PTVs [7].